As Japan’s matcha growers seek official recognition, they join a long lineage of producers whose names — such as Champagne, Harris Tweed, Parmigiano Reggiano — are protected by law.

In Japan, the powdered green tea known globally as matcha is now at the intersection of tradition, global demand, and legal identity. With exports surging and a key growth market emerging overseas, producers and regional associations are moving to secure formal origin protection. In July, the Kyoto Prefectural Tea Chamber applied to register tencha — the shaded tea leaves ground into matcha—under Japan’s Geographical Indication (GI) system. The proposed designation would ensure that only tea produced in Kyoto Prefecture from hand-picked first-flush leaves could carry the certification mark.

The push comes amid mounting pressure on supply. Severe heatwaves in Japan’s tea-growing regions have slashed yields and driven up prices. Kyoto’s farmers reported a 25 percent drop in tencha harvests as of July, while consumer demand has surged globally. The matcha market is projected to reach about $5 billion by 2028. For producers, a legal designation represents more than prestige. It is a strategic tool to protect authenticity and value in a market increasingly crowded with imitations.

Unlike Champagne or Roquefort, which are tied to specific locations and centuries of regulation, the word matcha means “ground tea.” The term just describes a routine processing method, “like the ‘cheddaring’ of dairy curds which gives cheddar cheese its un-trademark-able name,” one report notes. Securing a GI for matcha means building a legal and cultural narrative around place, process, and tradition, particularly in Kyoto, Uji, and Nishio, which have produced shaded green teas for more than eight centuries.

The move follows a broader global shift. Traditional origin protections once reserved for wine, cheese, and spirits are expanding to encompass foods, crafts, and agricultural products vulnerable to imitation. Japan’s Ministry of Agriculture, Forestry and Fisheries (MAFF) currently maintains about 130 registered geographical indications, including Kobe Beef and Yubari Melon, and has encouraged regional industries to pursue more. As matcha’s reputation becomes both cultural export and commodity, its producers are betting that legal origin protection will become essential to sustain credibility in the next phase of its global boom.

Geographical Indications

A geographical indication (GI) is a legally protected name that identifies a product as originating in a specific location where a particular quality, reputation, or characteristic is essentially attributable to that origin. The European Commission defines it as “a name which identifies a product as originating in a specific place, region or country where a given quality, reputation or other characteristic of the product is essentially attributable to its geographical origin.”

GIs operate as intellectual property rights based on geography rather than brand ownership. They are recognized under the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and, in the EU, administered through national agencies and the European Union Intellectual Property Office (EUIPO). The process is methodical: producers form a group, draft a technical file detailing production methods and geographic boundaries, and submit it for review by national authorities before EU-level examination. The process can take several years.

Once approved, a GI prevents unauthorized use of the protected name and blocks marketing that could mislead consumers about a product’s true origin. It also allows enforcement at customs and through trade agreements abroad. For producers, it transforms a regional specialty into an asset backed by law; for consumers, it offers a guarantee that origin, method, and quality are verifiable rather than rhetorical.

Japan’s matcha growers are now entering that arena — seeking to do for powdered green tea what France did for Champagne a century ago: turn geography into a mark of authenticity.

Other protected GI goods

Textiles and Crafts

Harris Tweed (Scotland)

Protected under the Harris Tweed Act of 1993, this woolen fabric must be handwoven by islanders in their homes in the Outer Hebrides and made from pure virgin wool dyed and spun locally. The Harris Tweed Authority inspects and certifies each bolt before export.

Murano Glass (Italy)

The Vetro Artistico Murano certification mark, created by regional law in 1994, protects glassware produced on the island of Murano using traditional methods. Only registered artisans and studios can use the trademark, which distinguishes genuine Murano craftsmanship from imported imitations.

Limoges Porcelain (France)

Granted a French indication géographique in 2017, Limoges porcelain can only be produced and decorated in Haute-Vienne. The protection ensures that centuries-old kiln traditions and clay-sourcing practices remain tied to the Limoges name.

Irish Linen (Northern Ireland)

Certified by the Irish Linen Guild, the trademark guarantees that the linen yarn is spun in Ireland and the fabric woven by guild members.

Spirits and Drinks

Champagne (France)

The Champagne Appellation d’Origine Contrôlée (AOC) is the prototype for origin-based protection. Only sparkling wines produced in the Champagne region under specific viticultural and winemaking rules may bear the name. The Comité Champagne monitors global misuse and maintains recognition in over 120 countries.

Scotch Whisky (Scotland)

Protected by the Scotch Whisky Regulations of 2009, the GI mandates distillation and maturation in Scotland for at least three years in oak casks. It is enforced globally by the Scotch Whisky Association and recognized under trade agreements worldwide.

Cognac (France)

The Bureau National Interprofessionnel du Cognac (BNIC) regulates the GI, defining the region, grape varieties, and double distillation method. Recent international rulings, such as South Korea’s recent decision rejecting a “Cognac” shampoo trademark, underscore its global legal strength.

Tequila (Mexico)

Recognized as a Denominación de Origen since 1974, Tequila production is limited to five Mexican states and regulated by the Consejo Regulador del Tequila (CRT). The GI enforces agave sourcing, distillation, and bottling standards.

Foods

Parmigiano Reggiano (Italy)

Protected by EU PDO status, the cheese must be produced in specific provinces of northern Italy using raw cow’s milk and aged at least twelve months. Each wheel is inspected and fire-branded by the consortium before sale.

Roquefort (France)

One of Europe’s oldest protected cheeses, Roquefort gained AOC status in 1925. It must be made from raw ewe’s milk and aged in the natural limestone caves of Roquefort-sur-Soulzon.

Prosciutto di Parma (Italy)

PDO protection confines production to Parma province, where the microclimate allows natural air curing. Each ham bears the Ducal Crown mark, attesting to its origin.

Darjeeling Tea (India)

India’s first registered GI, Darjeeling Tea’s protection dates to 2004. The Tea Board of India certifies that the tea comes from the Darjeeling district and meets plucking and processing standards.

Related on Ethos:

In a groundbreaking study published in the journal Biochemical Genetics, researchers have undertaken a detailed investigation into the immune-modulating properties of the microalga Chlorella vulgaris. This unicellular organism has captivated scientists due to its rich nutritional profile and potential health benefits. The research team, comprising Robben, Amin, and Budiman, utilized a well-established mouse model to assess the implications of Chlorella vulgaris on immune gene expression, providing insights that could pave the way toward novel therapeutic interventions in immunology.

The utilization of Chlorella vulgaris in nutritional science has surged in popularity, primarily because of its high protein content, essential fatty acids, vitamins, and minerals. However, its potential immunomodulatory effects were less explored until this recent inquiry. By dissecting the interactions between Chlorella vulgaris and the immune system, the researchers aimed to illuminate mechanisms that could enhance immune responses during challenging conditions, such as viral infections or autoimmune disorders.

To set the stage for their experiments, the research team designed a series of controlled studies involving various dose escalations of Chlorella vulgaris, administered to laboratory mice over a specified duration. This meticulous approach allowed them to observe not only the immediate effects but also the longer-term impact of this alga on the immune system. The researchers coated their assessments with rigorous statistical frameworks, ensuring the reliability and reproducibility of the results.

One of the notable findings of the study was the alteration in gene expression profiles associated with immune responses in the mice that received Chlorella vulgaris. Specific immune markers demonstrated significant upregulation, suggesting that the microalga could indeed stir various immune pathways to enhance the animal’s defensive capabilities. The scientists leveraged advanced techniques such as RNA sequencing to pinpoint the genes that exhibited pronounced changes in expression levels.

Interestingly, the immunomodulatory effects observed in the trial correlated with the concentration of Chlorella vulgaris administered. A detailed dose-response relationship emerged, with higher concentrations inducing more significant changes in immune functionality. This discovery prompts critical considerations regarding potential applications in dietary supplements or functional foods aimed at enhancing immune resilience in humans.

Equally fascinating was the exploration of cytokine profiles, which are crucial players in the immune response network. The administration of Chlorella vulgaris appeared to recalibrate the balance of pro-inflammatory and anti-inflammatory cytokines within the host. This shift could have profound implications, suggesting that this microalga may serve as a natural modulator of inflammation, a characteristic that could be leveraged in treating various inflammatory conditions.

Moreover, the study meticulously highlighted the underlying biochemical processes, shedding light on how specific phytonutrients and bioactive compounds present in Chlorella vulgaris may directly influence immune gene expression. By dissecting these complex interactions, the research significantly advances our understanding of the potential pharmacological applications of Chlorella vulgaris in immune modulation.

In addition to its implications for human health, the research possesses notable ecological significance. Given the increasing interest in sustainable and environmentally friendly food sources, Chlorella vulgaris emerges as a star player in the intersection of nutrition, health, and environmental sustainability. It can be cultivated efficiently, requiring minimal resources while offering considerable nutritional yields, thus providing a model for sustainable agricultural practices.

The implications of these findings extend beyond mere academic interest; they pose tantalizing prospects for the development of new therapeutic agents, particularly in the management of diseases where immune dysfunction is paramount. As the scientific community races to find effective treatments for immunological disorders, Chlorella vulgaris could represent a promising avenue for further investigation and development.

However, the research team acknowledges the necessity for follow-up studies involving human trials to fully validate the findings. While mouse models provide critical insights, translating these results into practical therapeutic applications requires further validation across different biological systems. The complexities of human immunology necessitate a cautious approach, with meticulous attention to detail in subsequent clinical studies.

The study ultimately reaffirms the potential of microalgae as beneficial dietary components, with Chlorella vulgaris leading the pack in terms of immune modulation. As we continue to explore the multifaceted roles of microalgae in our diet, the evidence continues to mount in favor of integrating such bioactive compounds into our daily nutrition.

In summary, Robben, Amin, and Budiman’s research marks a significant leap forward in our understanding of the nutritional and therapeutic potential inherent in Chlorella vulgaris. By elucidating its immunomodulatory effects in a controlled mouse model, this scientific endeavor opens the door to innovative health solutions that leverage natural products for enhanced immune resilience. As ongoing research seeks to refine these findings, the potential for Chlorella vulgaris to make waves in both the health and wellness sectors appears increasingly promising.

The findings intriguingly prompt a re-evaluation of dietary patterns, suggesting that incorporating foods rich in bioactive compounds can have profound implications on health. As consumers become more health-conscious and informed, the demand for functional foods that support immune health is expected to rise—making the timing of this research particularly relevant and impactful.

The broader implications of this study could also reshape how food scientists and nutritionists think about food sources, emphasizing the need for a more integrated approach to dietary planning and health management. By harnessing nature’s bounty and combining it with scientific rigor, a new frontier in health optimization may be on the horizon.

As we digest the findings presented by this research, it remains essential to maintain a dialogue within the scientific community, fostering collaboration and continued investigation into the health benefits of natural products. With each new study, we inch closer to unlocking the secrets behind the remarkable capabilities of microalgae, potentially transforming the health landscape for generations to come.

In conclusion, Chlorella vulgaris stands out not just as a superfood but as an emerging player in the field of immunology. As we continue to explore the depths of its potential, it becomes increasingly clear that the future of nutritional science may very well be green, with microalgae at the forefront of our efforts to enhance health and well-being globally.

Subject of Research: Immunomodulatory Activity of Chlorella vulgaris

Article Title: Evaluation of Immune Gene Expression Reveals Immunomodulatory Activity of Chlorella vulgaris in a Mouse Model

Article References: Robben, D.M., Amin, Z., Budiman, C. et al. Evaluation of Immune Gene Expression Reveals Immunomodulatory Activity of Chlorella vulgaris in a Mouse Model. Biochem Genet (2025). https://doi.org/10.1007/s10528-025-11262-5

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s10528-025-11262-5

Keywords: Chlorella vulgaris, Immunology, Immune Gene Expression, Nutritional Science, Microalgae, Cytokines, Immunomodulation, Health Benefits, Sustainable Food Sources.

Tags: autoimmune disorders researchChlorella vulgaris immune responsedose escalation studies Chlorellaessential fatty acids nutritionimmune gene expression studyimmune-modulating propertiesmicroalga health benefitsmouse model immunologynutritional science Chlorellaprotein-rich microalgatherapeutic interventions in immunologyviral infections immune response

190,322,800 Ordinary Shares of Green Tea Group Limited are subject to a Lock-Up Agreement Ending on 15-NOV-2025. These Ordinary Shares will be under lockup for 184 days starting from 15-MAY-2025 to 15-NOV-2025.

Details:

Each of the Controlling Shareholders agrees and undertakes to our Company and each of the Sponsor-Overall Coordinators, the Overall Coordinators, the Joint Global Coordinators, the Joint Sponsors, the Joint Bookrunners, the Joint Lead Managers, the Capital Market Intermediaries and the Hong Kong Underwriters that except pursuant to the Global Offering (including pursuant to the Over-allotment Option), at any time after the date of the Hong Kong Underwriting Agreement up to and including the date falling the First Six-Month Period, it/he/she will not, without the prior written consent of the Sponsor-Overall Coordinators (for themselves and on behalf of the Hong Kong Underwriters): (a) sell, offer to sell, contract or agree to sell, mortgage, charge, pledge, hypothecate, hedge, lend, grant or sell any option, warrant, contract or right to purchase, grant or purchase any option, warrant, contract or right to sell, or otherwise transfer or dispose of or create an Encumbrance over, or agree to transfer or dispose of or create an Encumbrance over, either directly or indirectly, conditionally or unconditionally, any Shares or any other securities of the Company or any interest in any of the foregoing (including any securities convertible into or exchangeable or exercisable for or that represent the right to receive, or any warrants or other rights to purchase, any Shares or any other securities of the Company) beneficially owned by it as at the Listing Date (the ?Locked-up Securities?); (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Locked-up Securities; (c) enter into any transaction with the same economic effect as any transaction specified in (a) or (b) above; or (d) offer to or agree to do any of the foregoing or announce any intention to do so, in each case, whether any of the foregoing transactions is to be settled by delivery of share capital or such other securities, in cash or otherwise (whether or not the issue of such share capital or other equity securities will be completed within the First Six-Month Period); and (i) during the Second Six-Month Period, each of our Controlling Shareholders will not enter into any transaction described in paragraphs (a), (b) and (c) above or agree or contract to or publicly announce any intention to enter into any such transaction if, immediately following such transaction, the shareholding of Time Sonic in the Company will be reduced to below 30%; and (ii) until the expiry of the Second Six-Month Period, in the event that he/she enters into any such transactions specified in paragraphs (a), (b) or (c) above or agrees or contracts to, or publicly announces an intention to enter into any such transactions, each of our Controlling Shareholders will take all reasonable steps to ensure that he/she will not create a disorderly or false market in the securities of our Company. The restrictions above do not apply to any pledge or charge of any Shares or other equity securities of the Company, as applicable, or any interest in any of the foregoing (including, without limitation, any securities convertible into or exchangeable or exercisable for or that represent the right to receive, or any warrants or other rights to purchase, any Shares or other equity securities of the Company) after the Global Offering in favor of an authorized institution as defined in the Banking Ordinance (Cap. 155 of the Laws of Hong Kong) for a bona fide commercial loan.

Each Cornerstone Investor has agreed that it will not, and will cause its affiliates not to, whether directly or indirectly, at any time during the period of six months from (and inclusive of) the Listing Date (the ?Lock-up Period?), dispose of, in any way, any of the Offer Shares or any interest in any company or entity holding such Offer Shares that they have purchased pursuant to the relevant Cornerstone Investment Agreement, save for certain limited circumstances, such as transfers to any of its wholly-owned subsidiaries who will be bound by the same obligations of such Cornerstone Investor, including the Lock-up Period restriction.

Colon cleanses or enemas, which are encouraged as a part of Sonne’s 7-day cleanse, come with their risks. Colon cleansing involves flushing large amounts of water or other substances through the rectum and into the colon.

Plus, the Sonne’s 7-day cleanse, as well as many similar cleanses, promote the use of products that may not be safe.

“Packaged cleanses typically fall within the realm of dietary supplements, which are largely unregulated,” says Whitney Linsenmeyer, PhD, RD, a spokesperson for the Academy of Nutrition and Dietetics and an assistant professor of nutrition and dietetics at Saint Louis University in Missouri. “These may contain unlisted substances and may interact with other medications or supplements you are taking.”